Does LANADELUMAB Cause Injection site rash? 25 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Injection site rash have been filed in association with LANADELUMAB (TAKHZYRO). This represents 1.2% of all adverse event reports for LANADELUMAB.
25
Reports of Injection site rash with LANADELUMAB
1.2%
of all LANADELUMAB reports
0
Deaths
8
Hospitalizations
How Dangerous Is Injection site rash From LANADELUMAB?
Of the 25 reports, 8 (32.0%) required hospitalization, and 1 (4.0%) were considered life-threatening.
Is Injection site rash Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LANADELUMAB. However, 25 reports have been filed with the FAERS database.
What Other Side Effects Does LANADELUMAB Cause?
Hereditary angioedema (1,343)
Product dose omission issue (555)
Weight decreased (361)
Weight increased (353)
Inappropriate schedule of product administration (318)
Product use issue (229)
Covid-19 (225)
Injection site pain (201)
Insurance issue (172)
Drug ineffective (142)
What Other Drugs Cause Injection site rash?
ETANERCEPT (3,781)
DUPILUMAB (3,566)
ADALIMUMAB (2,108)
TIRZEPATIDE (1,131)
IXEKIZUMAB (526)
DULAGLUTIDE (501)
EVOLOCUMAB (465)
TERIPARATIDE (426)
SARILUMAB (424)
HYDROXYPROGESTERONE CAPROATE (384)
Which LANADELUMAB Alternatives Have Lower Injection site rash Risk?
LANADELUMAB vs LANADELUMAB-FLYO
LANADELUMAB vs LANREOTIDE
LANADELUMAB vs LANSOPRAZOLE
LANADELUMAB vs LANTHANUM
LANADELUMAB vs LANTUS